摘要
近年来心肌能量代谢性药物通过联合常规改善血流药物(硝酸酯类、β-受体阻滞剂、强心苷等)治疗心肌缺血备受关注,这类药物通过转换心肌能量代谢方式,减少产生单位能量的耗氧量,在不影响机体血流动力学的基础上,明显改善患者心肌缺血及心功能,达到抗心绞痛的作用〔1〕。因此该类药物可作为辅助治疗缺血性心脏病的选择。
出处
《中国老年学杂志》
CAS
CSCD
北大核心
2014年第6期1733-1735,共3页
Chinese Journal of Gerontology
参考文献10
-
1陈力量,殷兰芳,章纪平.磷酸肌酸钠治疗老年多病因心力衰竭的临床疗效[J].心血管康复医学杂志,2011,20(6):570-572. 被引量:10
-
2李佳彧,倪维华,李佳睿,马丕勇,杨萍.左卡尼汀对急性心肌梗死大鼠TGF-β1表达的影响[J].中国实验诊断学,2011,15(9):1444-1446. 被引量:6
-
3宋涛,李臣文,赵文秀,葛志明.心肌缺血的能量代谢及代谢药物治疗[J].实用心脑肺血管病杂志,2006,14(10):766-768. 被引量:13
-
4Jolanta Pekala,Bozena Patkowska-Sokola,Robert Bodkowski,Dorota Jamroz,Piotr Nowakowski,Stanislaw Lochynski,Tadeusz Librowski.L-Carnitine - Metabolic Functions and Meaning in Humans Life[J]. Current Drug Metabolism . 2011 (7)
-
5Khalid Abozguia,Perry Elliott,William McKenna,Thanh Trung Phan,Ganesh Nallur-Shivu,Ibrar Ahmed,Abdul R. Maher,Kulvinder Kaur,Jenny Taylor,Anke Henning,Houman Ashrafian,Hugh Watkins,Michael Frenneaux.Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy[J]. Circulation . 2010 (16)
-
6Fanny Vaillant,Panayota Tsibiribi,Giampiero Bricca,Bernard Bui-Xuan,Anne Bescond-Jacquet,Alain Tabib,Jacques Descotes,Quadiri Timour.Trimetazidine Protective Effect Against Ischemia-Induced Susceptibility to Ventricular Fibrillation in Pigs[J]. Cardiovascular Drugs and Therapy . 2008 (1)
-
7Bernhard J. Riedel,Janos Gal,Gillian Ellis,Paul J. Marangos,Anthony W. Fox,David Royston.Myocardial Protection Using Fructose-1,6-Diphosphate During Coronary Artery Bypass Graft Surgery: A Randomized, Placebo-Controlled Clinical Trial[J]. Anesthesia & Analgesia . 2004 (1)
-
8Shawn C Black.In vivo models of myocardial ischemia and reperfusion injury[J]. Journal of Pharmacological and Toxicological Methods . 2000 (2)
-
9Angel K. Markov,Michael A. Brumley,Alfredo Figueroa,Thomas N. Skelton,Patrick H. Lehan.Hemodynamic effects of fructose 1,6-diphosphate in patients with normal and impaired left ventricular function[J]. American Heart Journal . 1997 (5)
-
10Sabino Iliceto,Domenico Scrutinio,Paolo Bruzzi,Gaetano D’Ambrosio,Luca Boni,Matteo Di Biase,Giuseppina Biasco,Paul G. Hugenholtz,Paolo Rizzon.Effects of l -carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the l -Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trial[J]. Journal of the American College of Cardiology . 1995 (2)
二级参考文献26
-
1叶兴蓉,彭华生,王炜,孙海清,王晓湘.磷酸肌酸治疗老年慢性心力衰竭的临床观察[J].中国老年学杂志,2006,26(10):1410-1411. 被引量:44
-
2Stanley WC,Lopaschuk GD,Hal JL,et al.Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions.Potential for pharmacological interventions[J].Cardiovas Res,1997,33:243-257.
-
3Korrald C,Elvenes OP,Myrmel T,et al.Myocardial substrate metabolism influences left ventricular energtics in vivo[J].Am J Physiol,2000,278:1345 -1351.
-
4Lopaschuk GD.Optimizing cardiac energy metabolism:how can fatty acid and carbohydrate metabolism be manipulated[J] ? Coron Artery Dis,2001,12:8-11.
-
5Jackson G,Fesc F.Combination therapy in angna:a review of combined hyemodynamic treatment and the role for combined hyemodyanmic and cardinc metabolic agents[J].Int J Clin Pract,2001,55:256-261.
-
6Vander Horst IC,Zijlstra F,van't-Hof AW,et al.Glucose -insulin-potassium infusion in patients treatedwith primary angioplasty for acute myocardial infarction the glucose-insulin-potassium study:a randomized tria[J].J Am Coll Cardiol,2003,42:784-791.
-
7Sack MN,Yellon DM.Insulin therapy as an adjunct to reperfusion after acute coronary ischemia:a proposed direct myocardial cell survival effect independent of metabolic modulation[J].J Am Coll Cardiol,2003,41:1404-1407.
-
8Marzilli M.Cardioprotective effects of trimetazidine:a review[J].Curr Med Res Opin,2003,9:661-672.
-
9Marzilli M,Klein WW.Efficacy and tolerability of trimetazidinein stable angina:A meta-analysis of randomized,double-blind,controlled trials[J].Cor Artery Dis,2003,14:171-179.
-
10Vitale C,Wajngaten M,Sposato B,et al.Trimetazidine improves ventricular function and quality of life in elderly patients with coronary artery disease[J].Eur Heart J,2004,25:1814-1821.
共引文献26
-
1胡元会,吴华芹,马铁民,陈双厚,刘瑞华,张百舜,程慧平,褚瑜光,房玉涛,石洁,何建成,曹雪滨.心复康口服液对心梗后心衰大鼠心肌三磷酸腺苷含量的影响[J].时珍国医国药,2009,20(5):1029-1030. 被引量:9
-
2邵静萍,张善飞,陈渊成,杨文亮,柳晓泉.丹酚酸B在心肌细胞和血管内皮细胞内的摄取特性[J].中国药科大学学报,2009,40(3):263-268. 被引量:4
-
3简维雄,袁肇凯,黄献平,陈清华,郑景辉,李勇华,王丽萍.冠心病心血瘀阻证血浆代谢组学的检测分析[J].中国中西医结合杂志,2010,30(6):579-584. 被引量:57
-
4王东晓,朱曼,黄翠丽.我院老年CCU病区心肌能量代谢支持药物利用调查[J].药物流行病学杂志,2010,19(11):630-633. 被引量:3
-
5唐瑞康.左卡尼汀治疗心血管疾病的临床应用[J].当代医学,2012,18(18):22-24. 被引量:13
-
6梁俊红,曹建玺.卡托普利对充血性心力衰竭患者心功能的影响[J].中国社区医师(医学专业),2013,15(4):195-195. 被引量:2
-
7陶余华.磷酸肌酸钠治疗慢性心力衰竭的疗效分析[J].中国卫生产业,2013,10(3):76-76.
-
8陈丽,何燕青.磷酸肌酸钠治疗慢性肺源性心脏病心力衰竭60例疗效观察[J].现代诊断与治疗,2013,24(9):1997-1997.
-
9陈丽,何燕青.磷酸肌酸钠治疗慢性肺源性心脏病合并心力衰竭60例疗效观察[J].现代诊断与治疗,2013,24(8):1777-1778. 被引量:1
-
10马彬.磷酸肌酸钠对高血压引起的慢性心功能不全患者的疗效分析[J].实用临床医药杂志,2013,17(24):102-103. 被引量:3
同被引文献19
-
1宋涛,李臣文,赵文秀,葛志明.心肌缺血的能量代谢及代谢药物治疗[J].实用心脑肺血管病杂志,2006,14(10):766-768. 被引量:13
-
2Pekala J, Patkowska-Sokota B, Bodkowski R, et al. L-carnitine- -metabolic functions and meaning in humans life [ J ] . Curr Drug Metab, 2011, 12 (7) : 667-678.
-
3殷仁富,陈金明.心肌能量学:代谢与治疗[M].上海:第二军医大学出版社,2002:263-270.
-
4Gao X, He X, Luo B, et al. Angiotensin II increases collagen I expression via transforming growth factor-betal and extracellular signal-regulated kinase in cardiac fibroblasts [ J ] . Eur J Pharmacol, 2009, 606 ( 1/3 ) : 115-120.
-
5Sundqvist A, Ten Dijke P, Van Dam H. Key signaling nodes in mammary gland development and cancer : Smad signal integration in epithelial cell plasticity [ J ] . Breast Cancer Res, 2012, 14 ( 1 ) : 204.
-
6Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor ( TGF ) - β signaling in cardiac remodeling [ J ]. J Mol Cell Cardiol, 2011, 51 (4): 600-606.
-
7Ratkaj I, Bujak M, Jurisic D, et al. Microarray analysis of Dupuytren' s disease cells : the profibrogenic role of the TGF- β inducible p38 MAPK pathway [ J ] . Cell Physiol Biochem, 2012, 30 ( 4 ) : 927-942.
-
8Van Bilsen M, Smeets PJ, Gilde AJ, et al. Metabolic remodelling of the failing heart : the cardiac burn-out syndrome? [ J ] . Cardiovase Res, 2004, 61 ( 2 ) : 218-226.
-
9Gambert S, Vergely C, Filomenko R, et al. Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts [ J ] . Mol Cell Biochem, 2006, 283 ( 1/2 ) : 147- 152.
-
10Tuunanen H, Knuuti J. Metabolic remodelling in human heart failure [ J ] . Cardiovasc Res, 2011, 90 ( 2 ) : 251-257.
二级引证文献9
-
1郑雄,武云峰,朱军辉,刘磊.左卡尼汀对行非体外循环冠状动脉搭桥术患者微循环和心肌酶的影响[J].现代医学,2018,46(10):1111-1114. 被引量:1
-
2欧阳山丹,林珍,李阿云.左卡尼汀对维持性血液透析患者肾性贫血的疗效及心脏结构和功能的影响[J].贵州医科大学学报,2019,44(5):601-605. 被引量:24
-
3赵贵盛.左卡尼汀对慢性肾衰竭透析患者心力衰竭的价值[J].中国继续医学教育,2020,12(15):141-142. 被引量:1
-
4刘万福,柳荫.针对性用药管理对心血管疾病患者用药问题的影响[J].血管与腔内血管外科杂志,2020,6(2):174-176. 被引量:5
-
5黎明,许锁春,闫炀,王海晨,李勇新,易秋月,张永健,郝军军,邓超,王锐利,薛丽.围手术期使用左-卡尼汀对冠状动脉旁路移植术患者的心肌保护作用[J].中国医师杂志,2020,22(6):826-829. 被引量:1
-
6龙专,欧阳过,王敏,周骞,张建佳,赵吉锐.基于“气虚-能量代谢重塑”探讨马王堆导引术在慢性心力衰竭中的作用机制[J].湖南中医药大学学报,2020,40(11):1350-1354. 被引量:5
-
7饶志威,姜琼,柯秋林,龚亚红.某院重点监控药品药事管理实践与成效分析[J].湖北科技学院学报(医学版),2021,35(4):327-330.
-
8周静,刘复兴.某院2018—2021年心肌能量代谢药物临床应用调查及用药合理性评价[J].中国药物滥用防治杂志,2021,27(6):948-951. 被引量:1
-
9赵韶静,曾艳,李正东,张华.左卡尼汀对大鼠糖尿病肾病的保护作用分析[J].中国临床药理学与治疗学,2019,24(3):278-282. 被引量:7
-
1谭光强,郑企琨,谭丽娟,孙爱华.药物对缺血心肌能量的保护[J].中国医院药学杂志,1993,13(11):493-495.
-
2赵江龙,高大中.左卡尼汀治疗心血管系统疾病研究进展[J].中国药房,2009,20(26):2068-2070. 被引量:9
-
3常元媛,张智,管锦蓉.顺式阿曲库铵肌松作用的临床观察[J].江苏医药,2011,37(4):486-486.
-
4赵洪.略谈代谢性药物的相互作用[J].临床医药文献电子杂志,2016,3(59):11906-11906.
-
5田志,陈明.曲美他嗪的临床应用[J].第三军医大学学报,2005,27(7):685-687. 被引量:12
-
6徐亚宁,刘波,刘敏,张苏川.曲美他嗪对老年高血压患者左室肥厚及心功能的影响[J].求医问药(下半月刊),2012,10(6):206-207. 被引量:1
-
7李长玉,杨国柱.胰岛素还能干什么[J].糖尿病之友,2014(9):64-64.
-
8吕允凤,胡欣,张君仁,孙春华.心肌能量代谢改善药米屈肼[J].中国新药杂志,2005,14(11):1355-1358. 被引量:2
-
9孙丽爽,张英杰.他汀类药物对缺血再灌注心肌的保护作用及机制[J].心血管病学进展,2007,28(2):229-232. 被引量:8
-
10苗佩宏,徐江平.新型抗心绞痛药物雷诺嗪的研究进展[J].国外医学(药学分册),2003,30(4):197-200. 被引量:17